SYSTEMIC AND CORONARY HEMODYNAMICS AND PHARMACODYNAMICS OF ENALAPRIL AND ENALAPRILAT IN CONGESTIVE HEART-FAILURE

被引：6

作者：

CHATTERJEE, K

DEMARCO, T

机构：

[1] Division of Cardiology, University of California, San Francisco, California

来源：

DRUGS | 1990年 / 39卷

关键词：

D O I：

10.2165/00003495-199000394-00007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Enalapril is an effective angiotensin-converting enzyme (ACE) inhibitor which produces salutary, beneficial haemodynamic effects in patients with congestive heart failure. Enalapril also produces beneficial neurohumoral changes, as well as improving abnormal coronary haemodynamics and myocardial energetics that are frequently encountered in these patients. Administration of enalapril once or twice daily appears to be quite effective during maintenance therapy in patients with chronic congestive heart failure. © 1990, ADIS Press Limited. All rights reserved.

引用

页码：29 / 40

页数：12

共 43 条

[21] ENALAPRIL IN THE TREATMENT OF HYPERTENSION WITH RENAL-ARTERY STENOSIS [J].

HODSMAN, GP ;

BROWN, JJ ;

CUMMING, AMM ;

DAVIES, DL ;

EAST, BW ;

LEVER, AF ;

MORTON, JJ ;

MURRAY, GD ;

ROBERTSON, I ;

ROBERTSON, JIS .

BMJ-BRITISH MEDICAL JOURNAL, 1983, 287 (6403) :1413-1417

[22]

HOWLETT DR, 1983, BRIT J PAHRM, V79, P323

[23]

JACKSON B, 1984, AUSTR NZ J MED, V12, P355

[24] PLASMA ENALAPRIL LEVELS AND HORMONAL EFFECTS AFTER SHORT-TERM AND LONG-TERM ADMINISTRATION IN ESSENTIAL-HYPERTENSION [J].

JOHNSTON, CI ;

JACKSON, BJ ;

LARMOUR, I ;

CUBELLA, R ;

CASLEY, D .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 :S233-S239

[25]

KELEY J, 1985, BRIT J CLIN PHARMACO, V20, P264

[26]

KELLEY J, 1984, BRIT J CLIN PHARMACO, V18, P274

[27]

LAROCHELLE P, 1985, CLIN INVEST MED, V8, P197

[28] HEMODYNAMIC AND CLINICAL-RESPONSE TO ENALAPRIL, A LONG-ACTING CONVERTING-ENZYME INHIBITOR, IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].

LEVINE, TB ;

OLIVARI, MT ;

GARBERG, V ;

SHARKEY, SW ;

COHN, JN .

CIRCULATION, 1984, 69 (03) :548-553

[29]

MCCAA RE, 1984, FED PROC, V43, P1336

[30]

ODYA CE, 1983, J LAB CLIN MED, V102, P714

← 1 2 3 4 5 →